Clinical trial NCT05351333 - References

Spinal Cord Injuries — Conditioning & Open-Label Placebo (COLP) for Opioid Management in Intensive Inpatient Rehabilitation

Citation(s)

•   Ader R, Mercurio MG, Walton J, James D, Davis M, Ojha V, Kimball AB, Fiorentino D
  Conditioned pharmacotherapeutic effects: a preliminary study. Psychosom Med. 2010 Feb;72(2):192-7. doi: 10.1097/PSY.0b013e3181cbd38b. Epub 2009 Dec 22.
•   Bryce TN, Budh CN, Cardenas DD, Dijkers M, Felix ER, Finnerup NB, Kennedy P, Lundeberg T, Richards JS, Rintala DH, Siddall P, Widerstrom-Noga E
  Pain after spinal cord injury: an evidence-based review for clinical practice and research. Report of the Nati
•   Cardenas DD, Bryce TN, Shem K, Richards JS, Elhefni H
  Gender and minority differences in the pain experience of people with spinal cord injury. Arch Phys Med Rehabil. 2004 Nov;85(11):1774-81.
•   Carvalho C, Caetano JM, Cunha L, Rebouta P, Kaptchuk TJ, Kirsch I
  Open-label placebo treatment in chronic low back pain: a randomized controlled trial. Pain. 2016 Dec;157(12):2766-2772. doi: 10.1097/j.pain.0000000000000700. Erratum in: Pain. 2017 Feb;158
•   Chesterton LS, Sim J, Wright CC, Foster NE
  Interrater reliability of algometry in measuring pressure pain thresholds in healthy humans, using multiple raters. Clin J Pain. 2007 Nov-Dec;23(9):760-6.
•   Cleeland CS, Ryan KM
  Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singap. 1994 Mar;23(2):129-38. Review.
•   Colloca L, Tinazzi M, Recchia S, Le Pera D, Fiaschi A, Benedetti F, Valeriani M
  Learning potentiates neurophysiological and behavioral placebo analgesic responses. Pain. 2008 Oct 15;139(2):306-314. doi: 10.1016/j.pain.2008.04.021. Epub 2008 Jun 6.
•   Doering BK, Rief W
  Utilizing placebo mechanisms for dose reduction in pharmacotherapy. Trends Pharmacol Sci. 2012 Mar;33(3):165-72. doi: 10.1016/j.tips.2011.12.001. Epub 2012 Jan 25. Review.
•   Edwards RR, Sarlani E, Wesselmann U, Fillingim RB
  Quantitative assessment of experimental pain perception: multiple domains of clinical relevance. Pain. 2005 Apr;114(3):315-319. doi: 10.1016/j.pain.2005.01.007. Review.
•   Fregni F, Boggio PS, Lima MC, Ferreira MJ, Wagner T, Rigonatti SP, Castro AW, Souza DR, Riberto M, Freedman SD, Nitsche MA, Pascual-Leone A
  A sham-controlled, phase II trial of transcranial direct current stimulation for the treatment of central pain in
•   Giang DW, Goodman AD, Schiffer RB, Mattson DH, Petrie M, Cohen N, Ader R
  Conditioning of cyclophosphamide-induced leukopenia in humans. J Neuropsychiatry Clin Neurosci. 1996 Spring;8(2):194-201.
•   Institute of Medicine (US) Committee on Advancing Pain Research, Care, and Education
  Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Washington (DC): National Academies Press (US); 2011.
•   Kaptchuk TJ, Friedlander E, Kelley JM, Sanchez MN, Kokkotou E, Singer JP, Kowalczykowski M, Miller FG, Kirsch I, Lembo AJ
  Placebos without deception: a randomized controlled trial in irritable bowel syndrome. PLoS One. 2010 Dec 22;5(12):e15591. doi: 10.1
•   Kaptchuk TJ, Miller FG
  Placebo Effects in Medicine. N Engl J Med. 2015 Jul 2;373(1):8-9. doi: 10.1056/NEJMp1504023.
•   Le Bars D, Gozariu M, Cadden SW
  Animal models of nociception. Pharmacol Rev. 2001 Dec;53(4):597-652. Review.
•   Long-acting Opioids for Chronic Non-cancer Pain: A Review of the Clinical Efficacy and Safety [Internet]
  Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2015 Aug 27. Available from http://www.ncbi.nlm.nih.gov/books/NBK349988/
•   Martin WR, Eades CG, Thompson WO, Thompson JA, Flanary HG
  Morphine physical dependence in the dog. J Pharmacol Exp Ther. 1974 Jun;189(3):759-71.
•   McCance-Katz EF
  The Substance Abuse and Mental Health Services Administration (SAMHSA): New Directions. Psychiatr Serv. 2018 Oct 1;69(10):1046-1048. doi: 10.1176/appi.ps.201800281. Epub 2018 Aug 13.
•   Nielsen, S
  , et al., Comparing opioids: a guide to estimating oral morphine equivalents (OME) in research. National Drug and Alcohol Research Centre, University of NSW, 2014.
•   Pearce JM
  The placebo enigma. QJM. 1995 Mar;88(3):215-20. Review.
•   Perlis M, Grandner M, Zee J, Bremer E, Whinnery J, Barilla H, Andalia P, Gehrman P, Morales K, Thase M, Bootzin R, Ader R
  Durability of treatment response to zolpidem with three different maintenance regimens: a preliminary study. Sleep Med. 2015 Sep;16(
•   Price DD, Finniss DG, Benedetti F
  A comprehensive review of the placebo effect: recent advances and current thought. Annu Rev Psychol. 2008;59:565-90. Review.
•   Sandler AD, Glesne CE, Bodfish JW
  Conditioned placebo dose reduction: a new treatment in attention-deficit hyperactivity disorder? J Dev Behav Pediatr. 2010 Jun;31(5):369-75. doi: 10.1097/DBP.0b013e3181e121ed.
•   Schaefer M, Harke R, Denke C
  Open-Label Placebos Improve Symptoms in Allergic Rhinitis: A Randomized Controlled Trial. Psychother Psychosom. 2016;85(6):373-374. Epub 2016 Oct 15.
•   The Numerical Opioid Side Effect (NOSE) Assessment Tool
  Journal of Cancer Pain & Symptom Palliation, 2005. 1(3): p. 3-6.

Conditioning & Open-Label Placebo (COLP) for Opioid Management in Intensive Inpatient Rehabilitation

Details for clinical trial NCT05351333